Effect of (S)-3,5-DHPG on microRNA expression in mouse brain

Experimental Neurology

Volumn 235, Issue 2, 2012, Pages 497-507

  Lusardi, Theresa A ^a   Thompson, Simon J ^a   MacDonald, Ian C ^a   Lan, Jing Quan ^a   Theofilas, Panos ^a   Saugstad, Julie A ^a  

^a LEGACY RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,5 DIHYDROXYPHENYLGLYCINE; METABOTROPIC RECEPTOR 1; MICRORNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; BRAIN CORTEX; BRAIN REGION; BRAIN TISSUE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION REGULATION; GENE LOCATION; GENETIC CORRELATION; IN SITU HYBRIDIZATION; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE STUDY; RNA ANALYSIS; RNA SEQUENCE; TISSUE DISTRIBUTION;

ANIMALS; BRAIN; EXCITATORY AMINO ACID AGONISTS; GENE EXPRESSION REGULATION; GLYCINE; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; RECEPTORS, METABOTROPIC GLUTAMATE; RESORCINOLS;

EID: 84860381434     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2012.01.018     Document Type: Article

References (28)

1. Amaral P.P., Dinger M.E., Mercer T.R., Mattick J.S. The eukaryotic genome as an RNA machine. Science 2008, 319:1787-1789.
2. Brice N.L., Varadi A., Ashcroft S.J., Molnar E. Metabotropic glutamate and GABA(B) receptors contribute to the modulation of glucose-stimulated insulin secretion in pancreatic beta cells. Diabetologia 2002, 45:242-252.
3. de Groot J., Sontheimer H. Glutamate and the biology of gliomas. Glia 2011, 59(1181-1189):3107875.
4. Friedman R.C., Kai-How Farh K., Burge C.B., Bartel D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009, 19:92-105.
5. Git A., Dvinge H., Salmon-Divon M., Osborne M., Kutter C., Hadfield J., Bertone P., Caldas C. Systematic comparison of microarray profiling, real-time PCR, and next-generation sequencing technologies for measuring differential microRNA expression. RNA 2010, 16(991-1006):2856892.
6. Griffiths-Jones S., Saini H.K., van Dongen S., Enright A.J. miRBase: tools for microRNA genomics. Nucleic Acids Res. 2008, 36:D154-D158.
7. Guo H., Ingolia N.T., Weissman J.S., Bartel D.P. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010, 466:835-840.
8. Kim S.W., Li Z., Moore P.S., Monaghan A.P., Chang Y., Nichols M., John B. A sensitive non-radioactive northern blot method to detect small RNAs. Nucleic Acids Res. 2010, 38. e98 2853138.
9. Li S., Huang S., Peng S.B. Overexpression of G protein-coupled receptors in cancer cells: involvement in tumor progression. Int. J. Oncol. 2005, 27:1329-1339.
10. Lusardi T.A., Farr C.D., Faulkner C.L., Pignataro G., Yang T., Lan J., Simon R.P., Saugstad J.A. Ischemic preconditioning regulates expression of microRNAs and a predicted target, MeCP2, in mouse cortex. J. Cereb. Blood Flow Metab. 2010, 30:744-756.
11. Mineno J., Okamoto S., Ando T., Sato M., Chono H., Izu H., Takayama M., Asada K., Mirochnitchenko O., Inouye M. The expression profile of microRNAs in mouse embryos. Nucleic Acids Res. 2006, 34:1765-1771.
12. Namkoong J., Shin S.S., Lee H.J., Marin Y.E., Wall B.A., Goydos J.S., Chen S. Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma. Cancer Res. 2007, 67:2298-2305.
13. Papadopoulos G.L., Alexiou P., Maragkakis M., Reczko M., Hatzigeorgiou A.G. DIANA-mirPath: integrating human and mouse microRNAs in pathways. Bioinformatics 2009, 25:1991-1993.
14. Park C.S., Tang S.-J. Regulation of microRNA expression by induction of bidirectional synaptic plasticity. J. Mol. Neurosci. 2008, 38:50-56.
15. Paxinos G., Franklin K. The mouse brain in stereotaxic coordinates 2007, Academic Press, Inc. 3rd edition.
16. Potkin S.G., Macciardi F., Guffanti G., Fallon J.H., Wang Q., Turner J.A., Lakatos A., Miles M.F., Lander A., Vawter M.P., Xie X. Identifying gene regulatory networks in schizophrenia. Neuroimage 2010, 53(839-847):3055795.
17. Provost P. MicroRNAs as a molecular basis for mental retardation, Alzheimer's and prion diseases. Brain Res. 2010, 1338(58-66):2896967.
18. Rachidi M., Lopes C. Molecular and cellular mechanisms elucidating neurocognitive basis of functional impairments associated with intellectual disability in Down syndrome. Am. J. Intellect. Dev. Disabil. 2010, 115:83-112.
19. Satoh J. MicroRNAs and their therapeutic potential for human diseases: aberrant microRNA expression in Alzheimer's disease brains. J. Pharmacol. Sci. 2010, 114:269-275.
20. Saugstad J.A. MicroRNAs as effectors of brain function with roles in ischemia and injury, neuroprotection, and neurodegeneration. J. Cereb. Blood Flow Metab. 2010, 30:1564-1576.
21. Shin S.S., Martino J.J., Chen S. Metabotropic glutamate receptors (mGlus) and cellular transformation. Neuropharmacology 2008, 55(396-402):2605077.
22. Sonntag K.C. MicroRNAs and deregulated gene expression networks in neurodegeneration. Brain Res. 2010, 1338(48-57):2883630.
23. Stepulak A., Luksch H., Gebhardt C., Uckermann O., Marzahn J., Sifringer M., Rzeski W., Staufner C., Brocke K.S., Turski L., Ikonomidou C. Expression of glutamate receptor subunits in human cancers. Histochem. Cell Biol. 2009, 132:435-445.
24. Storto M., Capobianco L., Battaglia G., Molinaro G., Gradini R., Riozzi B., Di Mambro A., Mitchell K.J., Bruno V., Vairetti M.P., Rutter G.A., Nicoletti F. Insulin secretion is controlled by mGlu5 metabotropic glutamate receptors. Mol. Pharmacol. 2006, 69:1234-1241.
25. Tamminga J., Kathiria P., Koturbash I., Kovalchuk O. DNA damage-induced upregulation of miR-709 in the germline downregulates BORIS to counteract aberrant DNA hypomethylation. Cell Cycle 2008, 7:3731-3736.
26. Tang X., Gal J., Zhuang X., Wang W., Zhu H., Tang G. A simple array platform for microRNA analysis and its application in mouse tissues. RNA 2007, 13:1803-1822.
27. Wibrand K., Panja D., Tiron A., Ofte M.L., Skaftnesmo K.O., Lee C.S., Pena J.T., Tuschl T., Bramham C.R. Differential regulation of mature and precursor microRNA expression by NMDA and metabotropic glutamate receptor activation during LTP in the adult dentate gyrus in vivo. Eur. J. Neurosci. 2010, 31:636-645.
28. Yelamanchili S.V., Fox H.S. Defining larger roles for "tiny" RNA molecules: role of miRNAs in neurodegeneration research. J. Neuroimmune Pharmacol. 2010, 5(63-69):2881294.